Cancer

May 7, 2024

Study seeks to evaluate military exposures on veterans’ lung cancer risk 

A prospective cohort of veterans including those with military toxic exposures, such as burn pits, will be screened annually with low-dose chest CT to detect lung cancer and other disease early.

By Tom Wilemon
(photo by Erin O. Smith)
May 2, 2024

25th Annual VICC Scientific Retreat focuses on hereditary cancers

The Vanderbilt-Ingram Cancer Center 25th Annual Scientific Retreat will focus on hereditary cancers and feature nationally and internationally renowned speakers on the subject.

By Tom Wilemon
(photo by Erin O. Smith)
April 25, 2024

Making a splash for cancer research

The third annual Swim Across America – Nashville was held April 21 at Ensworth Natatorium on the Ensworth School’s Frist Campus. The event raises funds for research at Vanderbilt-Ingram Cancer Center.
(iStock image)
April 24, 2024

VUMC hosts symposium on stem cell transplants and cellular therapies

The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.

By Tom Wilemon
Jeffrey Rathmell, PhD, and Melissa Wolf, PhD. (photo by Susan Urmy)
April 22, 2024

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

By Bill Snyder
Jennifer Vega, PhD
April 22, 2024

Jennifer Vega receives NCCN Foundation Young Investigator Award

Jennifer Vega, PhD, a cognitive neuroscientist and research instructor in the Department of Psychiatry and Behavioral Sciences, has received a 2024 National Comprehensive Cancer Network Foundation Young Investigator Award.

By Tom Wilemon
April 18, 2024

New urine test has higher diagnostic accuracy for prostate cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.
By Tom Wilemon
April 15, 2024

Ray Blind named associate director for diversity, equity and inclusion at Vanderbilt-Ingram Cancer Center

Ray Blind, PhD, Ingram Assistant Professor of Cancer Research, has been named associate director for Diversity, Equity and Inclusion at Vanderbilt-Ingram Cancer Center
By Tom Wilemon
April 11, 2024

Cathy Eng to participate in April 15 congressional briefing

Cathy Eng, MD, will participate in a congressional briefing on April 15 focused on “Addressing Representation in Clinical Trials.”
By Tom Wilemon
April 8, 2024

Chris Williams named VICC director for Research Education

Chris Williams, MD, PhD, associate dean for Physician-Scientist Education and Training at Vanderbilt University, has been named to lead Research Education at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
April 8, 2024

Karen Winkfield named VICC director for Community Outreach and Engagement

Karen Winkfield, MD, PhD, Ingram Professor of Cancer Research, has been named associate director for Community Outreach and Engagement at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
April 5, 2024

Pietenpol to receive ASCO’s highest honor

Jennifer Pietenpol, PhD, will be recognized at the annual meeting of the American Society of Clinical Oncology (ASCO) with one of its highest honors.
By Tom Wilemon
April 5, 2024

Eunyoung Choi’s gastric cancer research merits AACR-Debbie’s Dream funding

Ongoing research by Eunyoung Choi, PhD, into how cells transform into abnormal versions of themselves that are the precursors to stomach cancer has received support from the American Association for Cancer Research.
By Tom Wilemon
1 2 3 4 5 6 … 68